Wong S H, Barrow N, Hall K, Gandesha P, Manson A
Eye Department, Guy & St Thomas' NHS Foundation Trust, London, UK.
Department of Neuro-ophthalmology, Moorfields Eye Hospital, London, UK.
Neuroophthalmology. 2021 May 10;45(4):246-252. doi: 10.1080/01658107.2021.1887287. eCollection 2021.
The increasing incidence of idiopathic intracranial hypertension (IIH) with the obesity epidemic is leading to increased pressures on service capacity. Evidence shows that group consultations (GCs) deliver effective, person-centred healthcare, but the feasibility for IIH is unknown. We set out to develop and test a safe and effective GC service for IIH. Through an interactive approach, we co-designed a bespoke in-person and virtual GC model, where patients are reviewed in a group setting. Improvements were made following each session following patient input and team reflections. Outcomes measured included patient satisfaction, self-perceived health literacy, and successful implementation of the GCs. During the pilot, eight in-person GCs were delivered: once-monthly (Oct-Dec 2019), then twice-monthly (Jan-Feb 2020). Feedback was received from 49/53 patients. 100% felt more satisfied and heard, 100% felt more involved in decision-making, 98% had a better understanding of their condition, 96% felt more able to cope with their condition and keep themselves healthy, 94% rated this as a positive experience, and 90% reported improved access and more time with their clinician compared with existing 1:1 appointments. Since September 2020, in response to the COVID-19 pandemic, we transitioned to weekly virtual GCs, receiving overwhelmingly positive feedback (median scores: patient satisfaction 9.5/10; being listened to by clinician 10/10; involved by clinician in treatment decisions 10/10; clinician explanation of treatment 10/10; and opportunity to discuss condition or treatment 10/10). GCs are safe and effective for IIH, and preferred in our patient cohort. This allowed ongoing high-quality, person-centred care despite challenges from the COVID-19 pandemic.
随着肥胖症流行,特发性颅内高压(IIH)的发病率不断上升,这给医疗服务能力带来了越来越大的压力。有证据表明,小组会诊(GCs)能提供有效、以患者为中心的医疗服务,但IIH患者接受小组会诊的可行性尚不清楚。我们着手为IIH患者开发并测试一种安全有效的小组会诊服务。通过互动方式,我们共同设计了一种定制的面对面和虚拟小组会诊模式,即在小组环境中对患者进行评估。每次会诊后,根据患者的反馈和团队的反思进行改进。测量的结果包括患者满意度、自我感知的健康素养以及小组会诊的成功实施情况。在试点期间,共进行了8次面对面小组会诊:2019年10月至12月为每月1次,然后2020年1月至2月为每两个月1次。53名患者中有49名提供了反馈。100%的患者感到更满意且被倾听,100%的患者感到在决策过程中有更多参与感,98%的患者对自己的病情有了更好的了解,96%的患者觉得更有能力应对自己的病情并保持健康,94%的患者将此评为积极的体验,90%的患者表示与现有的一对一预约相比,获得了更好的就医机会并且与临床医生交流的时间更多。自2020年9月起,为应对新冠疫情,我们转为每周进行虚拟小组会诊,收到了压倒性的积极反馈(中位数评分:患者满意度9.5/10;被临床医生倾听10/10;临床医生参与治疗决策10/10;临床医生对治疗的解释10/10;以及讨论病情或治疗的机会10/10)。小组会诊对IIH患者是安全有效的,并且在我们的患者群体中更受欢迎。这使得在新冠疫情带来的挑战下,仍能持续提供高质量、以患者为中心的护理。